News & Articles

The distinct evolutionary pathway of the fabella ‘re-emerging’ in humans could point to an evolutionary change

Synthetic data supports research to predict, diagnose and treat brain diseases

People with liver disease caused by eating too much sugar and fat could be at increased risk of developing serious neurological conditions like depression or dementia

Researchers have found that a third COVID-19 vaccine increases vaccine effectiveness

Heparin, a widely available and affordable drug, has been found to limit lung damage when inhaled by COVID-19 patients.

Researchers were able to detect cell free RNA in the blood of pregnant women which provided a molecular signature to identify women at risk of pre-eclampsia

Findings are an essential first step in understanding the safety and feasibility of using psilocybin as a potential treatment for a range of mental health conditions

A study by experts at King's College London has found that symptoms of early COVID-19 are similar to vaccine side-effects

Researchers from King’s College London provide a clue as to why patients with CHARGE syndrome are deaf

Adults who have received a double vaccination are 47% less likely to have long COVID

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks

The Synthetic Brain Project is using AI models powered by the Cambridge-1 supercomputer

Acute and prolonged food-induced inflammation can increase the predicted risk of developing cardiometabolic diseases like cardiovascular disease, new research has shown.

The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality

The supercomputer is designed to solve some of the world’s most pressing medical challenges

Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed

Post-menopausal women with lower levels of the female sex hormone estrogen appear to be at higher risk of developing serious complications of COVID-19

The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients

Researchers from King’s College London and Imperial College London have identified a method to manipulate ventilators to supply two patients independently

A team of academic clinicians from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust identified the novel method “LAMP”